Past catalysts on this ticker, reconciled against the announcement parse pipeline. Hover any row for the parsed outcome detail.
Generic dermatology portfolio's own upcoming catalysts alongside class-defining historical readouts and upcoming primary completion dates in the same mechanism classes. Each event moves the broader thesis for Generic dermatology portfolio. Showing past 6 months and next 12 months · 3 later hidden.
Same axes, same units. Discontinued and historical pivotal trials excluded; see Competitor Landscape below for the full set.
| Trial | Sponsor | Class | Phase / Line | Design | Primary endpoint | Dosing | Key eligibility | n |
|---|---|---|---|---|---|---|---|---|
| Generic dermatology portfolio | Mayne Pharma Group | Small Molecule Other | Approved | 0 | ||||
| Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients | Centre for Human Drug Research, Netherlands | — |
Read-across commentary attached per trial. Phase ordering preserved within each group.
External analyst notes, journalism, and industry commentary cited with attribution.
"Sponsor guided" dates come from IR materials and earnings calls; hover for the cited source. "CT.gov proxy" dates fall back to the registry primary completion date — actual readouts typically follow by 3-6 months.
| — |
| — |
| — |
| — |
| — |
| Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris | Badr University | — | Phase 4 | — | — | — | — | — |
| Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne | University of Pennsylvania | — | Phase 4 | — | — | — | — | — |
| A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients | Sun Pharmaceutical Industries Limited | — | Phase 4 | — | — | — | — | — |
| Randomized, Triple-Blind, Placebo-Controlled Trial of Topical Dapsone Gel in Patients With Acne Vulgaris | Oya Helin Dundar | — | Phase 4 | — | — | — | — | — |
| Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris | Jinnah Postgraduate Medical Centre | — | Phase 4 | — | — | — | — | — |
| Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS | Peking Union Medical College | — | Phase 4 | — | — | — | — | — |
| Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. | Integrative Skin Science and Research | — | Phase 4 | — | — | — | — | — |
| Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo | Bausch Health Americas, Inc. | — | Phase 4 | — | — | — | — | — |
| Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa | Novartis Pharmaceuticals | — | Phase 3 | — | — | — | — | — |
| Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast | South Valley University | — | Phase 3 | — | — | — | — | — |
| The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol | Dr.dr.Irma Bernadette, SpKK (K) | — | Phase 3 | — | — | — | — | — |
| A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2) | PPM Services S.A. | — | Phase 3 | — | — | — | — | — |
| A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1) | PPM Services S.A. | — | Phase 3 | — | — | — | — | — |
| A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT) | PPM Services S.A. | — | Phase 3 | — | — | — | — | — |
| A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa | UCB Biopharma SRL | — | Phase 3 | — | — | — | — | — |
| Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients | Centre Hospitalier Universitaire de Nice | — | Phase 3 | — | — | — | — | — |
| Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | — | Phase 3 | — | — | — | — | — |
| A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa | Incyte Corporation | — | Phase 3 | — | — | — | — | — |
| A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris | Galderma R&D | — | Phase 3 | — | — | — | — | — |
| Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris | Eurofarma Laboratorios S.A. | — | Phase 3 | — | — | — | — | — |
| A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) | Novartis Pharmaceuticals | — | Phase 3 | — | — | — | — | — |
| A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa | Novartis Pharmaceuticals | — | Phase 3 | — | — | — | — | — |
| 1% Clascoterone Cream for the Treatment Acne Vulgaris | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | — | Phase 3 | — | — | — | — | — |
| A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks. | Equipmed USA LLC | — | PHASE2/PHASE3 | — | — | — | — | — |
| Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome | Hasanuddin University | — | PHASE2/PHASE3 | — | — | — | — | — |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Bluefin Biomedicine, Inc. | — | PHASE2/PHASE3 | — | — | — | — | — |
| Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa | Novartis Pharmaceuticals | — | Phase 2 | — | — | — | — | — |
| Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults | Biofrontera Inc. | — | Phase 2 | — | — | — | — | — |
| The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment | Universitas Padjadjaran | — | Phase 2 | — | — | — | — | — |
| Anifrolumab for Hidradenitis Suppurativa | University of North Carolina, Chapel Hill | — | Phase 2 | — | — | — | — | — |
| A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa | Avalo Therapeutics, Inc. | — | Phase 2 | — | — | — | — | — |
| Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne | Shenzhen People's Hospital | — | Phase 2 | — | — | — | — | — |
| Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne | Xiyuan Hospital of China Academy of Chinese Medical Sciences | — | Phase 2 | — | — | — | — | — |
| Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study | Assiut University | — | Phase 2 | — | — | — | — | — |
| Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris | Jiangxi Kvvit Pharmaceutical Co., Ltd. | — | Phase 2 | — | — | — | — | — |
| Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense | Zura Bio Inc | — | Phase 2 | — | — | — | — | — |
| Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa | Incyte Corporation | — | Phase 2 | — | — | — | — | — |
| Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy | Stanford University | — | PHASE1/PHASE2 | — | — | — | — | — |
| A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. | Shanghai Huaota Biopharmaceutical Co., Ltd. | — | PHASE1/PHASE2 | — | — | — | — | — |
| Lipidome and Microbiome Profile of Acne | University of California, Davis | — | PHASE1/PHASE2 | — | — | — | — | — |
| Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris | Yohanes Firmansyah, dr, MH, MM | — | PHASE1/PHASE2 | — | — | — | — | — |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne | Sanofi Pasteur, a Sanofi Company | — | PHASE1/PHASE2 | — | — | — | — | — |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne | Sanofi Pasteur, a Sanofi Company | — | PHASE1/PHASE2 | — | — | — | — | — |